Over the entire cohort, melanoma-specific survival (MSS) was influenced by CD2, PDL1 (CD274), and MITF (p = 0.01, p = 0.003, p = 0.03, respectively, Figure 6a–c). The gene discussed is CD2; the disease is melanoma.